Chapter 22 Part 3 Flashcards
1
Q
Pharming
A
Adolescents raiding medicine cabinets for drugs.
2
Q
Pharming Party
A
Event where teens trade and use prescription drugs.
3
Q
CNS Stimulants
A
Drugs that excite the central nervous system.
4
Q
CNS Depressants
A
Drugs that depress the central nervous system.
5
Q
Narcotics
A
CNS depressants derived from opium or synthetic sources.
6
Q
Hallucinogens
A
Psychedelic drugs causing hallucinations and altered perception.
7
Q
Volatile Inhalants
A
Substances inhaled for psychoactive effects.
8
Q
Signs and Symptoms
A
Physical indicators of drug or alcohol abuse.
9
Q
Oxy-Contin
A
Common painkiller abused at pharming parties.
10
Q
Demerol
A
Opioid pain medication often misused.
11
Q
Ritalin
A
Stimulant prescribed for attention-deficit disorders.
12
Q
Adderall
A
Stimulant used to treat ADHD, commonly abused.
13
Q
Dexedrine
A
Stimulant for ADHD, potential for misuse.
14
Q
Tachycardia
A
Increased heart rate, common in stimulant abuse.
15
Q
Bradycardia
A
Decreased heart rate, often seen with narcotics.
16
Q
Hypotension
A
Low blood pressure, can occur with depressants.
17
Q
Respiratory Depression
A
Decreased breathing effectiveness, risk with narcotics.
18
Q
Euphoria
A
Intense happiness, often experienced with depressants.
19
Q
Agitation
A
Restlessness or excitement, common with stimulants.
20
Q
Open Airway
A
First step in emergency care for overdose.
21
Q
Positive Pressure Ventilation
A
Technique to assist inadequate breathing.
22
Q
Scene Safety
A
Priority in managing substance abuse emergencies.
23
Q
Calming the Patient
A
Important to prevent injury during agitation.
24
Q
Respiratory distress
A
Signs indicating difficulty in breathing.
25
Hypoxia
Insufficient oxygen in the tissues.
26
Hypoxemia
Low oxygen levels in the blood.
27
Nasal cannula
Device for delivering oxygen through the nose.
28
Lateral recumbent position
Side-lying position to protect the airway.
29
Supine position
Lying flat on the back.
30
Hallucinogen
Substance causing altered perception and mood.
31
Environmental Emergencies
Situations requiring temperature regulation and care.
32
Tympanic thermometer
Device measuring temperature via the ear.
33
Blood glucose level
Measurement of glucose concentration in blood.
34
Hypoglycemia
Condition of abnormally low blood sugar.
35
Restraints
Devices used to limit patient movement.
36
Prone position
Lying flat on the stomach.
37
Reassessment
Ongoing evaluation of a patient's condition.
38
CNS stimulant
Substance increasing central nervous system activity.
39
CNS depressant
Substance decreasing central nervous system activity.
40
Airway obstruction
Blockage preventing airflow to the lungs.
41
Suctioning
Removing fluids or secretions from the airway.
42
Hyperventilation
Rapid or deep breathing causing decreased carbon dioxide.
43
Skin color assessment
Evaluating skin for signs of distress.
44
Heart rate variability
Fluctuations in heart rate during assessment.
45
Vomitus
Material expelled from the stomach.
46
Secretions
Fluids produced by the body, often obstructive.
47
CNS Stimulants
Drugs causing excitability and increased alertness.
48
Excitability
Increased emotional arousal and restlessness.
49
Tachycardia
Elevated heart rate above normal levels.
50
Dilated Pupils
Enlarged pupils, indicating possible drug influence.
51
CNS Depressants
Substances that reduce brain activity and arousal.
52
Euphoria
Intense feelings of happiness and well-being.
53
Bradycardia
Slowed heart rate, often below 60 bpm.
54
Narcotics
Opioids that relieve pain but can depress respiration.
55
Lethargy
State of sluggishness and reduced energy.
56
Hallucinogens
Substances causing altered perceptions and hallucinations.
57
Paranoia
Intense anxiety or fear, often irrational.
58
Volatile Inhalants
Substances causing intoxication through inhalation.
59
Erratic Blood Pressure
Unpredictable fluctuations in blood pressure readings.
60
Drug Withdrawal
Symptoms occurring after cessation of substance use.
61
Tremors
Involuntary muscle contractions or shaking.
62
Emergency Care Protocol
Steps for managing drug or alcohol emergencies.
63
Positive Pressure Ventilation
Assisted breathing technique for inadequate respiration.
64
Lateral Recumbent Position
Side-lying position to maintain airway patency.
65
Reassessment Frequency
Regular monitoring of vital signs and condition.
66
Seizure Emergency Protocol
Guidelines for managing seizure activity.
67
Mental Status Assessment
Evaluation of consciousness and cognitive function.
68
Naloxone Administration
Opioid overdose treatment via intramuscular or intranasal.
69
Transport Protocol
Guidelines for safely moving the patient.
70
Talk-Down Technique
Method to calm patients experiencing drug-induced anxiety.
71
Bad Trip
Intense anxiety or panic from hallucinogen use.
72
Hallucinogens
Drugs causing altered perceptions and reality distortion.
73
Marijuana Emergencies
Psychological effects more common than physical symptoms.
74
Prolonged Psychotic Reactions
Extended mental disturbances from hallucinogen use.
75
Personal Space
Physical area around a person that should not be invaded.
76
Verbalize
Encourage patients to express their feelings and experiences.
77
Self-Identification
Recognizing familiar objects to ground the patient.
78
PCP
Hallucinogen that can exacerbate agitation in users.
79
Drug Withdrawal
Symptoms experienced when a dependent user stops taking drugs.
80
Tolerance
Need for larger doses to achieve same drug effects.
81
Psychological Dependence
Compulsive behavior focused on acquiring drugs.
82
Physiological Dependence
Body requires drug to avoid withdrawal symptoms.
83
Cumulative Effects
Long-term consequences from years of substance abuse.
84
Acute Intoxication
Immediate effects of consuming excessive alcohol or drugs.
85
Signs of Alcohol Abuse
Indicators of long-term alcohol consumption issues.
86
Sympathetic Approach
Remain calm and understanding during patient interaction.
87
Establish Rapport
Build trust before physical contact with the patient.
88
Mental Clarity
State of clear thinking that may follow confusion.
89
Nonjudgmental Attitude
Maintain neutrality when interacting with distressed patients.
90
Transport After Calming
Move patient only after they have stabilized.
91
Reassurance
Provide comfort that drug effects are temporary.
92
Narcotics
Drugs that relieve pain and induce sleep.
93
Alcohol Use Disorder
Condition characterized by problem drinking and addiction.
94
Sedatives
Drugs that calm or induce sleep.
95
Hypnotics
Medications that induce sleep or sedation.
96
Barbiturates
Depressant drugs used for anxiety and sleep.
97
Cocaine
Stimulant drug that increases energy and alertness.
98
Marijuana
Psychoactive drug from cannabis plant.
99
Withdrawal Symptoms
Signs that occur after stopping drug use.
100
Anxiety
Feeling of worry or unease.
101
Agitation
State of nervousness or restlessness.
102
Profuse Sweating
Excessive perspiration due to withdrawal.
103
Piloerection
Goosebumps caused by withdrawal symptoms.
104
Elevated Heart Rate
Increased pulse due to withdrawal.
105
Hallucinations
Perceptions without external stimuli, visual or auditory.
106
Tactile Hallucinations
Feeling sensations that aren't present.
107
Nausea
Feeling of sickness with an urge to vomit.
108
Abdominal Cramping
Pain in the stomach area during withdrawal.
109
Delirium Tremens (DTs)
Severe alcohol withdrawal with confusion and agitation.
110
Wernicke-Korsakoff Syndrome
Brain disorder from alcohol toxicity and malnutrition.
111
Alcohol Intoxication Signs
Odor, swaying, slurred speech, and drowsiness.
112
Alcohol Emergencies
Critical situations arising from alcohol use.
113
Life Support Management
Care provided to stabilize vital functions.
114
Aspiration Risk
Danger of inhaling vomit into lungs.
115
Paralysis of the eyes
Loss of eye movement control due to syndrome.
116
Dementia
Cognitive decline affecting memory and reasoning.
117
Hypothermia
Abnormally low body temperature condition.
118
Inability to sort fiction from reality
Difficulty distinguishing between real and imagined events.
119
Coma
State of prolonged unconsciousness.
120
Hypertension
High blood pressure condition.
121
Altered mental status
Changes in cognitive function from liver issues.
122
Cirrhosis of the liver
Severe liver scarring affecting function.
123
Liver failure
Liver degeneration leading to fatty deposits.
124
Pancreatitis
Inflammation of the pancreas causing pain.
125
Cardiomyopathy
Heart muscle disease affecting function.
126
Peritonitis
Inflammation of the abdominal lining.
127
Chronic gastric ulcer
Long-lasting sore in the stomach lining.
128
Bone marrow suppression
Reduced blood cell production in the marrow.
129
Upper gastrointestinal hemorrhage
Bleeding in the upper digestive tract.
130
Seizures
Sudden, uncontrolled electrical disturbances in the brain.
131
Subdural hematoma
Blood collection between the brain and its outer covering.
132
Fractures from falls
Broken bones due to repeated falls.
133
Hypoglycemia
Low blood sugar levels causing symptoms.
134
Pneumonia
Lung infection causing breathing difficulties.
135
Pruritus
Severe itching of the skin.
136
Clotting disorders
Conditions affecting blood coagulation.
137
Withdrawal syndrome
Symptoms after reducing or stopping substance use.
138
Alcohol withdrawal syndrome
Symptoms mimicking psychiatric disorders after alcohol reduction.
139
Delirium tremens
Severe alcohol withdrawal with high mortality risk.
140
Alcoholic tremulousness
Early withdrawal symptoms including tremors and insomnia.
141
Alcoholic hallucinosis
Hallucinations occurring during alcohol withdrawal.
142
Withdrawal seizures
Seizures occurring during alcohol withdrawal.
143
Mortality rate of delirium tremens
Approximately 15-20% without treatment.
144
Duration of delirium tremens
Lasts between 1 to 5 days.
145
Severe confusion
Disorientation and inability to think clearly.
146
Loss of memory
Inability to recall past events or information.
147
Tremors
Involuntary muscle shaking or quivering.
148
Restlessness and irritability
Increased agitation and inability to relax.
149
Extremely high fever
Body temperature significantly above normal levels.
150
Dilated pupils
Enlarged pupils indicating potential distress or drug use.
151
Profuse sweating
Excessive perspiration beyond normal levels.
152
Insomnia
Inability to sleep or disrupted sleep patterns.
153
Elevated blood pressure
Blood pressure higher than normal range.
154
Tachycardia
Abnormally rapid heart rate exceeding normal limits.
155
Nausea and vomiting
Feeling sick and expelling stomach contents.
156
Diarrhea
Frequent, watery bowel movements.
157
Hallucinations
Perceptions of things not present, often frightening.
158
Opioid
Agent mimicking morphine effects on the body.
159
Opiate
Natural agents derived from opium.
160
Narcotic
Agents inducing sleep, broader than opioids.
161
Fentanyl
Synthetic opioid, 50-100 times more potent than morphine.
162
Carfentanil
Synthetic opioid, 100 times more potent than fentanyl.
163
Nitazenes
New class of synthetic opioids identified post-mortem.
164
CNS depression
Reduced central nervous system activity and responsiveness.
165
Respiratory depression
Decreased breathing rate and volume.
166
Miosis
Constricted pupils, common in opioid toxicity.
167
Seizure
Result of hypoxia from respiratory depression.
168
Psychomotor delay
Caused by hypoxia and cell injury.
169
Dysarthria
Speech disturbance due to facial muscle paralysis.
170
Ataxia
Incoordination resulting from hypoxia and cell injury.
171
Tremors
Involuntary muscle contractions from hypoxia.
172
Crackles
Sound from acute pulmonary edema and hypoxia.
173
Hearing loss
Altered metabolism affecting ear function.
174
Hypotension
Low blood pressure due to CNS depression.
175
Bradycardia
Slow heart rate from central nervous system effects.
176
Nausea
Vomiting due to decreased gastrointestinal motility.
177
Urinary retention
Inability to urinate from urethral sphincter spasm.
178
Pruritus
Itching caused by histamine release.
179
Flushing
Skin redness from histamine release.
180
Urticaria
Hives resulting from histamine release.
181
Hypoglycemia
Low blood sugar with unclear mechanism.
182
Hypothermia
Lowered body temperature with unclear mechanism.
183
Naloxone
Medication used to reverse opioid overdose effects.
184
Patient Care Goals
Focus on rapid intervention and prevention of arrest.
185
Inclusion Criteria
Decreased mental status with suspected opioid use.
186
Exclusion Criteria
Altered mental status from non-opioid causes.
187
PPE
Personal protective equipment for patient management.
188
Opioids
Drugs with minimal vapor pressure, low exposure risk.
189
Naloxone
Opioid antagonist for respiratory depression treatment.
190
Intravenous route
Provides predictable bioavailability for naloxone administration.
191
Intranasal route
Alternative naloxone delivery method via nasal spray.
192
Intramuscular route
Naloxone delivery method using muscle injection.
193
Nebulized solution
Medication delivery option for naloxone administration.
194
Respiratory depression
Reduced breathing effectiveness, often due to opioids.
195
Titration
Incremental adjustment of naloxone dosage for effect.
196
Pediatric dose
Specific naloxone dosage for children, varies by route.
197
Adult dose
Typical naloxone dosage range for adults, varies by route.
198
Adhesive patch
Form of opioids for transdermal absorption, remove if found.
199
Blood-borne pathogens
Infections transmitted through blood, risk from needle sticks.
200
Bag valve mask
Device for providing ventilatory support to patients.
201
Assessment
Evaluation of airway, breathing, circulation, and mental status.
202
Hypoxia
Low oxygen levels, assessed with pulse oximetry.
203
Hypoglycemia
Low blood sugar, can alter mental status.
204
Hypotension
Low blood pressure, potential cause of altered mental state.
205
Traumatic head injury
Possible cause of altered mental status requiring assessment.
206
Auto-injector
Pre-measured naloxone device for layperson use.
207
Mucosal atomization device (MAD)
Needleless syringe for intranasal naloxone delivery.
208
Single-use bottle
Container for naloxone nasal spray, designed for one use.
209
Public access programs
Initiatives providing naloxone to non-medical responders.
210
Cardiac arrest
Condition where naloxone is ineffective for treatment.
211
Naloxone
Opioid antagonist used to reverse respiratory depression.
212
Respiratory Depression
Decreased breathing rate or effort, critical in overdose.
213
Airway Management
Ensuring adequate oxygenation and ventilation in patients.
214
Opioid Withdrawal
Agitation or violence post-naloxone due to withdrawal.
215
High-Potency Opioids
Opioids requiring larger naloxone doses for reversal.
216
Fentanyl
Potent opioid, available in various legal forms.
217
Carfentanil
Extremely potent opioid, used for large animals.
218
Synthetic Opioids
Man-made opioids, often undetectable in tests.
219
Combination Analgesics
Opioids mixed with other analgesics like acetaminophen.
220
Vicodin
Combination of acetaminophen and hydrocodone.
221
Percocet
Combination of acetaminophen and oxycodone.
222
Percodan
Combination of aspirin and oxycodone.
223
Suboxone
Combination of buprenorphine and naloxone.
224
QT Prolongation
Potential toxic effect of methadone overdose.
225
Chest Wall Rigidity
Muscle stiffness requiring PEEP in fentanyl overdoses.
226
Miosis
Pinpoint pupils, a sign of opioid overdose.
227
Decreased Mental Status
Altered consciousness due to opioid effects.
228
PEEP
Positive end-expiratory pressure for ventilation support.
229
Accidental Overdose
Unintentional opioid overdose from misuse or abuse.
230
Toxicity Risks
Increased when opioids are mixed with other substances.
231
Monitoring Duration
Naloxone effects last about one hour; monitor closely.
232
Scene Safety
Ensure safety due to potential violent withdrawal.
233
Naloxone Administration
Administered to reverse opioid effects and restore breathing.
234
Ventilation
Critical intervention before naloxone in overdose cases.
235
Naloxone
Generic name for opioid overdose reversal medication.
236
Narcan
Trade name for naloxone medication.
237
Opioid Intoxication
Condition requiring naloxone for CNS depression.
238
Respiratory Depression
Inadequate breathing requiring immediate medical intervention.
239
Positive Pressure Ventilation
Technique to assist inadequate breathing in patients.
240
Mucosal Atomizer Device
Device used for intranasal naloxone administration.
241
Intranasal Route
Common route for naloxone administration by EMTs.
242
Intramuscular Route
Alternative route for naloxone, less commonly used.
243
Dosage for Intranasal
Typical dose is 4 mg per nostril.
244
Hypotension
Low blood pressure, a sign of opioid overdose.
245
Bradycardia
Slow heart rate, indicating possible opioid effects.
246
Airway Management
First step in emergency care for overdose.
247
Oxygenation
Maintaining adequate oxygen levels in the patient.
248
Suctioning Airway
Clearing airway to prevent aspiration during overdose.
249
Patient Restraint
Consideration due to potential aggression post-naloxone.
250
Contraindication of Naloxone
Known hypersensitivity to naloxone is the only contraindication.
251
Naloxone Administration Steps
Follow specific steps for safe naloxone delivery.
252
Carfentanyl
A potent opioid requiring higher naloxone doses.
253
Physiologic Instability
Condition needing larger naloxone doses or ALS unit.
254
Nasal Cannula
Device for administering supplemental oxygen.
255
Lateral Recumbent Position
Position to prevent aspiration in unresponsive patients.
256
Emergency Medical Care Steps
Sequential actions for managing opioid overdose.
257
CNS Depression
Central nervous system impairment due to opioids.
258
Naloxone Auto-Injector
Device for easy naloxone administration.
259
Naloxone
Opioid antagonist that reverses opioid effects.
260
Opioid Receptors
Sites where opioids bind to exert effects.
261
Acute Opioid Withdrawal
Symptoms occurring after sudden opioid cessation.
262
Respiratory Depression
Decreased breathing rate and effectiveness.
263
Hypotension
Abnormally low blood pressure condition.
264
Bradycardia
Abnormally slow heart rate.
265
Reassessment
Monitoring vital signs post-naloxone administration.
266
Redose
Administer additional naloxone if needed.
267
PCP
Dangerous hallucinogen with numerous street names.
268
Cocaine
Highly addictive stimulant with severe health risks.
269
Crack Cocaine
Smokable form of nearly pure cocaine.
270
Amphetamines
Stimulants that excite the central nervous system.
271
Methamphetamines
Powerful stimulant with high addiction potential.
272
Hyperthermia
Elevated body temperature, potentially life-threatening.
273
Muscle Rigidity
Stiffness of muscles, can occur with stimulants.
274
Hallucinogenic Amphetamines
Amphetamines that cause hallucinations and altered perception.
275
Street Names
Common names used for illicit drugs.
276
Nasal Dryness
Dryness of nasal passages, possible side effect.
277
Edema
Swelling due to fluid retention, can occur nasally.
278
Congestion
Blockage of nasal passages, often due to inflammation.
279
Monitoring
Continuous observation of patient's vital signs.
280
Transport
Moving patient while ensuring stability and safety.
281
Emergency Care Considerations
Special protocols for treating drug-related emergencies.
282
PABS
Psychoactive bath salts, synthetic designer drugs.
283
CNS Stimulant
Drug that stimulates the central nervous system.
284
Norepinephrine
Neurotransmitter involved in arousal and alertness.
285
Dopamine
Neurotransmitter linked to pleasure and reward.
286
Tolerance
Reduced response to a drug after prolonged use.
287
Withdrawal
Symptoms experienced after cessation of drug use.
288
Sympathetic Stimulation
Increased activity of the sympathetic nervous system.
289
Tachycardia
Abnormally rapid heart rate.
290
Hypertension
Elevated blood pressure.
291
Hyperthermia
Dangerously high body temperature.
292
Altered Mental Status
Changes in awareness or cognitive function.
293
Paranoia
Intense, irrational distrust or suspicion.
294
MDMA
Methylenedioxymethamphetamine, known as ecstasy.
295
Euphoria
Intense feeling of happiness or well-being.
296
Rave Culture
Subculture centered around electronic dance music events.
297
Bruxism
Involuntary teeth grinding or jaw clenching.
298
Mydriasis
Dilation of the pupils.
299
Hyperpyrexia
Life-threatening elevation of core body temperature.
300
Intracranial Hemorrhage
Bleeding within the skull.
301
Acute Respiratory Distress Syndrome
Severe lung condition causing breathing difficulties.
302
Emergency Management
Supportive care for drug overdose situations.
303
Extreme agitation
Intense restlessness or excitement in behavior.
304
Involuntary eye movement
Uncontrolled horizontal and vertical eye motions.
305
Unresponsiveness to pain
Lack of reaction to painful stimuli.
306
Severe muscular rigidity
Stiffness of muscles, limiting movement.
307
Excessive bronchial secretions
Increased mucus production in airways.
308
Hypertension
Elevated blood pressure above normal levels.
309
Hyperthermia
Abnormally high body temperature.
310
Decreased urinary output
Lower than normal urine production.
311
Respiratory depression
Reduced breathing rate or effort.
312
Vivid hallucinations
Intense sensory experiences without external stimuli.
313
Sensation of bugs crawling
Feeling of insects on or under the skin.
314
Myocardial infarction (MI)
Heart attack due to blocked blood flow.
315
Aortic dissection
Tear in the aorta's wall, causing separation.
316
Chest pain unrelated to MI
Discomfort not linked to heart attack causes.
317
Stroke
Interruption of blood supply to the brain.
318
Severe headache
Intense pain not relieved by analgesics.
319
Cheyne-Stokes respirations
Pattern of alternating apnea and breathing.
320
Neurological problems
Issues affecting the nervous system functions.
321
Psychiatric problems
Mental health issues like anxiety or psychosis.
322
Tetrahydrocannabinol (THC)
Main psychoactive compound in cannabis.
323
Medical marijuana
Cannabis used for therapeutic purposes.
324
Undesired side effects of THC
Negative reactions like dry mouth and tachycardia.
325
Impaired Attention
Decreased ability to focus due to drug use.
326
Motor Vehicle Accidents
Crashes linked to impaired driving from substances.
327
Tolerance
Reduced response to a substance after repeated use.
328
Withdrawal
Symptoms experienced after stopping a substance.
329
Synthetic Cannabinoids
Manufactured chemicals mimicking THC effects.
330
New Psychoactive Substances (NPS)
Unregulated drugs with mind-altering effects.
331
Herbal Incense
Dried plants sprayed with synthetic cannabinoids.
332
E-cigarettes
Devices for vaporizing liquids, including synthetic cannabinoids.
333
Synthetic Marijuana
Common name for synthetic cannabinoids, misleadingly labeled safe.
334
Addictive Substances
Drugs that create dependence and withdrawal symptoms.
335
Cannabinoid Hyperemesis Syndrome
Condition causing nausea and vomiting in chronic users.
336
Acute Episodes
Short-term occurrences of symptoms lasting days.
337
Hot Shower Relief
Temporary symptom relief for cannabinoid hyperemesis syndrome.
338
Cyclic Vomiting
Recurrent vomiting pattern over extended periods.
339
Periumbilical Pain
Abdominal pain around the navel area.
340
Emergency Care
Supportive treatment for patients under drug influence.
341
Tachycardia
Rapid heart rate often associated with drug use.
342
Adverse Effects
Negative reactions from drug use, including anxiety.
343
Violent Behavior
Aggressive actions potentially linked to drug effects.
344
Suicidal Thoughts
Mental health risks associated with synthetic cannabinoids.
345
Dehydration Risks
Fluid loss from vomiting and hot baths.
346
Acute Renal Failure
Kidney failure risk from untreated hyperemesis syndrome.
347
Overdose
Excessive intake of medication, intentional or accidental.
348
Intentional Overdose
Overdose aimed at suicide or drug effect.
349
Accidental Overdose
Unintentional excessive medication intake due to misunderstanding.
350
Synergistic Drug Interaction
Enhanced effects from combining multiple medications.
351
Calcium Channel Blockers
Medications that prevent calcium from entering cells.
352
Beta Blockers
Drugs that reduce heart rate and blood pressure.
353
Cardioactive Steroids
Steroids affecting heart function and rhythm.
354
ACE Inhibitors
Medications that relax blood vessels and lower blood pressure.
355
Anti-dysrhythmics
Drugs used to treat abnormal heart rhythms.
356
Benzodiazepines
Sedatives used for anxiety and sleep disorders.
357
Tricyclic Antidepressants (TCAs)
Older class of antidepressants with sedative effects.
358
Selective Serotonin Reuptake Inhibitors (SSRIs)
Antidepressants that increase serotonin levels.
359
Monoamine Oxidase Inhibitors (MAOIs)
Antidepressants that inhibit monoamine oxidase enzyme.
360
Acetaminophen
Common pain reliever, potential for liver toxicity.
361
NSAIDs
Nonsteroidal anti-inflammatory drugs for pain relief.
362
Antihistamines
Drugs that relieve allergy symptoms.
363
Herbal Remedies
Natural substances used for medicinal purposes.
364
Dietary Supplements
Products taken to enhance diet and health.
365
Hypotension
Lower than normal blood pressure.
366
Huffing
Inhaling substances for psychoactive effects.
367
Toluene
Chemical commonly used in huffing, found in solvents.
368
Hypoxia
Deficiency in oxygen reaching tissues.
369
Emergency Care Protocol
Guidelines for managing poisoning and overdose cases.
370
Toxidrome
Clinical syndrome associated with specific toxin exposure.
371
Decontamination
Process of removing toxins from the body.
